UCB Chooses Gwinnett County, Georgia for $2B Biologics Manufacturing Facility Creating 330 Jobs

UCB has selected Gwinnett County, Georgia, for a new $2 billion biologics manufacturing facility, expected to create around 330 permanent jobs and generate approximately $5 billion in economic impact. The state-of-the-art, 460,000-square-foot facility will utilize AI, robotics, and automation, reinforcing UCB's commitment to the U.S. market and its global biologics manufacturing network.

Published Mar 26, 2026

UCB has announced the establishment of a $2 billion biologics manufacturing facility in Gwinnett County, Georgia. The 460,000-square-foot facility will be located on 79 acres within the Rowen innovation district and is designed to produce biologics around the clock for the U.S. market.

AI-curated by Theia

This investment is projected to create approximately 330 permanent jobs and over 1,000 construction jobs. UCB's decision reflects its commitment to long-term growth and innovation in the U.S., with the project expected to generate a total economic impact of $5 billion. The facility will leverage advanced technologies including AI and robotics, enhancing UCB's global supply chain resilience.